Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection

Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection (UAB/UMN SPORE in Pancreatic Cancer)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00584363

Acronym

SPORE

Enrollment

731

Registered

2008-01-02

Start date

2004-06-30

Completion date

2017-09-30

Last updated

2017-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Brief summary

The purpose of the study is to collect pancreatic tissue, blood and urine from adults to study pancreatic abnormalities.

Detailed description

The aim of the study is to standardize, collect and share pancreatic cancer related information, to be used for research purposes only by researchers from different participating institutions/centers.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

Inclusion criteria

* Person over 19 years of age, patient with a tissue-proven diagnosis of pancreatic cancer at the University of Alabama at Birmingham (UAB) University Hospital during the period, and cognitive ability to provide informed consent

Exclusion criteria

* Person not 19 or older and have not had a tissue-proven diagnosis of pancreatic cancer.

Design outcomes

Primary

Measure	Time frame
To diagnose Pancreatic Cancer	5 years

Secondary

Measure	Time frame
Preventing patient form being misdiagnosed	5 years

Countries

United States

Outcome results